New-Onset Vitiligo During Treatment with Secukinumab: Report of Two Cases and Review of the Literature

New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases

L. Méry‐Bossard, K. Bagny, G. Chaby et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 86 citations

Medicine, Dermatology, Immunology +15

IL‐17A is not a treatment target in progressive vitiligo

Reinhart Speeckaert, Sofie Mylle, Nanja van Geel · Pigment Cell & Melanoma Research · 2019 · 68 citations

Life Sciences, Dermatology, Immunology +16

Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study

Jung Min Bae, Miri Kim, Han Hee Lee et al. · Journal of Investigative Dermatology · 2017 · 67 citations

Medicine, Immunology, Pharmacotherapy +8

Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea

Jung Min Bae, June Hyunkyung Lee, Jae Seung Yun et al. · Journal of the American Academy of Dermatology · 2017 · 51 citations

Medicine, Dermatology, Endocrinology +12

Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?

Joon Min Jung, Ye Jin Lee, Chong Hyun Won et al. · Annals of Dermatology · 2015 · 24 citations · Full text

Medicine, Dermatology, Immunology +17